Coherus Biosciences (NASDAQ:CHRS) jumped into today’s pre-holiday close after Mizuho’s Salim Syed says he’s heard the company canceled from next week’s Piper Jaffray conference.
A brief spike pushed the company to a 5.9% gain in the waning minutes before it settled for a 3.4% gain on the day.
The company was set to present at Piper’s healthcare event in New York Tuesday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.